Skip to main content
SpringerLink
Log in

Brain metastases of metastatic malignant melanoma: Response to DTIC and interferon-gamma

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

The prognosis of patients with malignant melanoma and brain metastases is poor. Therapy of brain metastases is difficult and mostly unsuccessful, with brain metastases being the predominant factor which determines overall survival. We report here on a patient whose brain metastases responded to DTIC+INF-gamma. We present a short summary on the different effects on INF-alpha and INF-gamma and reach the conclusion that clinical trials which combine DTIC and INF-gamma should be performed. Based on this observation, combinations including INF-alpha are not necessarily comparable to modalities which include INF-gamma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Merimsky O, Inbar M, Reider-Groswasser I, Chaitchik S: Brain metastases of malignant melanoma in interferon complete responders: clinical and radiological observations. J Neuro-Oncol 12: 137–140, 1992

    Google Scholar 

  2. Tveit KM, Endresen L, Rugstad HE, Fodstad O, Pihl A: Comparison of two soft-agar methods for assaying chemosensitivity of human tumoursin vitro: malignant melanomas. Br J Cancer 44: 539–544, 1981

    Google Scholar 

  3. Castello G, Ruocco V, Satriano RA, Zarrilli D: Role of interferons in the therapy of melanoma. Melanoma Res 1: 311–325, 1991

    Google Scholar 

  4. Mannering GJ, Deoria LB: The pharmacology and toxicology of the interferons: an overview. Ann Rev Pharmacol Toxicol 26: 455–515, 1986

    Google Scholar 

  5. Creagan ET: Interferon trials in the management of malignant melanoma and other neoplasms: an overview. Cancer Treat Res 35: 167–194, 1987

    Google Scholar 

  6. Hersey P, McLeod GR, Thomson DB: Treatment of advanced malignant melanoma with recombinant interferon alfa-2a in combination with DTIC. Brit J Haematol 79 (Suppl I) 60–66, 1991

    Google Scholar 

  7. Ho VC, Sober AJ: Therapy for cutaneous melanoma: An update. J Am Acad Dermatol 22: 159–176, 1990

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Dermatology, FU, Universitätsklinikum Rudolf Virchow, Berlin

    Dirk Schadendorf, Margitta Worm & Beate M. Czarnetzki

Authors
  1. Dirk Schadendorf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Margitta Worm
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Beate M. Czarnetzki
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schadendorf, D., Worm, M. & Czarnetzki, B.M. Brain metastases of metastatic malignant melanoma: Response to DTIC and interferon-gamma. J Neuro-Oncol 16, 77–79 (1993). https://doi.org/10.1007/BF01324838

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01324838

Key words

Search

Navigation